- Home
- ABVC vs HBIO Comparison
ABVC vs HBIO Comparison
Compare ABVC & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- HBIO
- Stock Information
- Founded
- ABVC 2015
- HBIO 1901
- Country
- ABVC United States
- HBIO United States
- Employees
- ABVC N/A
- HBIO N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ABVC Health Care
- HBIO Industrials
- Exchange
- ABVC Nasdaq
- HBIO Nasdaq
- Market Cap
- ABVC 22.1M
- HBIO 19.6M
- IPO Year
- ABVC N/A
- HBIO 2000
- Fundamental
- Price
- ABVC $3.39
- HBIO $0.45
- Analyst Decision
- ABVC
- HBIO Buy
- Analyst Count
- ABVC 0
- HBIO 2
- Target Price
- ABVC N/A
- HBIO $3.00
- AVG Volume (30 Days)
- ABVC 713.8K
- HBIO 1.2M
- Earning Date
- ABVC 08-13-2025
- HBIO 08-11-2025
- Dividend Yield
- ABVC N/A
- HBIO N/A
- EPS Growth
- ABVC N/A
- HBIO N/A
- EPS
- ABVC N/A
- HBIO N/A
- Revenue
- ABVC $508,383.00
- HBIO $91,397,000.00
- Revenue This Year
- ABVC $735.18
- HBIO N/A
- Revenue Next Year
- ABVC N/A
- HBIO $9.75
- P/E Ratio
- ABVC N/A
- HBIO N/A
- Revenue Growth
- ABVC 1904.43
- HBIO N/A
- 52 Week Low
- ABVC $0.40
- HBIO $0.28
- 52 Week High
- ABVC $5.48
- HBIO $3.48
- Technical
- Relative Strength Index (RSI)
- ABVC 58.50
- HBIO 49.68
- Support Level
- ABVC $3.30
- HBIO $0.39
- Resistance Level
- ABVC $3.92
- HBIO $0.48
- Average True Range (ATR)
- ABVC 0.65
- HBIO 0.03
- MACD
- ABVC -0.04
- HBIO -0.00
- Stochastic Oscillator
- ABVC 41.57
- HBIO 67.67
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.